| Dr Alexander Gotesman, MD | |
|
1374 Whitehorse Hamilton Square Rd, Hamilton, NJ 08690-3701 | |
| (609) 586-1319 | |
| Not Available |
| Full Name | Dr Alexander Gotesman |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 25 Years |
| Location | 1374 Whitehorse Hamilton Square Rd, Hamilton, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003002072 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 221653 (New York) | Secondary |
| 208800000X | Urology | 25MA09130400 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lakewood Urology Limited Liability Company | 9032293709 | 9 |
News Archive
World Food Program delegates "on Wednesday stressed the need for major food aid for North Korea, while a cautious South Korea called for transparent distribution of any assistance," Agence France-Presse reports.
A strategy where living kidney donors are paid $10,000, with the assumption that this strategy would increase the number of transplants performed by 5% or more, would be less costly and more effective than the current organ donation system, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
In a new study published in Frontiers in Microbiology, Mark Eppinger, assistant professor in the Department of Biology at The University of Texas at San Antonio describes innovative strategies to track disease-causing pathogens like E. coli. Eppinger hopes his research will aid in halting and preventing large-scale outbreaks.
Sigma-Aldrich® today announced the launch of a unique life science-focused application for the social media site, Facebook. Developed and marketed by Sigma® Life Science, the 'What's Your Favorite Gene?' application is the first and currently only application of its kind available on Facebook, and provides a platform that can enable scientists and researchers to network with each other and facilitate discussion based on their favorite genes, identifiable via gene functionality and biological pathways.
Sanofi and its subsidiary Genzyme announced today positive top-line results from CARE-MS I, the first of two randomized, Phase 3 clinical trials comparing the investigational drug alemtuzumab to the approved multiple sclerosis therapy Rebif in patients with relapsing-remitting multiple sclerosis.
› Verified 4 days ago
| Entity Name | Lakewood Urology Limited Liability Company |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356569388 PECOS PAC ID: 9032293709 Enrollment ID: O20080220000319 |
News Archive
World Food Program delegates "on Wednesday stressed the need for major food aid for North Korea, while a cautious South Korea called for transparent distribution of any assistance," Agence France-Presse reports.
A strategy where living kidney donors are paid $10,000, with the assumption that this strategy would increase the number of transplants performed by 5% or more, would be less costly and more effective than the current organ donation system, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
In a new study published in Frontiers in Microbiology, Mark Eppinger, assistant professor in the Department of Biology at The University of Texas at San Antonio describes innovative strategies to track disease-causing pathogens like E. coli. Eppinger hopes his research will aid in halting and preventing large-scale outbreaks.
Sigma-Aldrich® today announced the launch of a unique life science-focused application for the social media site, Facebook. Developed and marketed by Sigma® Life Science, the 'What's Your Favorite Gene?' application is the first and currently only application of its kind available on Facebook, and provides a platform that can enable scientists and researchers to network with each other and facilitate discussion based on their favorite genes, identifiable via gene functionality and biological pathways.
Sanofi and its subsidiary Genzyme announced today positive top-line results from CARE-MS I, the first of two randomized, Phase 3 clinical trials comparing the investigational drug alemtuzumab to the approved multiple sclerosis therapy Rebif in patients with relapsing-remitting multiple sclerosis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexander Gotesman, MD 1586 E 14th St, Brooklyn, NY 11230-7134 Ph: (347) 564-8694 | Dr Alexander Gotesman, MD 1374 Whitehorse Hamilton Square Rd, Hamilton, NJ 08690-3701 Ph: (609) 586-1319 |
News Archive
World Food Program delegates "on Wednesday stressed the need for major food aid for North Korea, while a cautious South Korea called for transparent distribution of any assistance," Agence France-Presse reports.
A strategy where living kidney donors are paid $10,000, with the assumption that this strategy would increase the number of transplants performed by 5% or more, would be less costly and more effective than the current organ donation system, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
In a new study published in Frontiers in Microbiology, Mark Eppinger, assistant professor in the Department of Biology at The University of Texas at San Antonio describes innovative strategies to track disease-causing pathogens like E. coli. Eppinger hopes his research will aid in halting and preventing large-scale outbreaks.
Sigma-Aldrich® today announced the launch of a unique life science-focused application for the social media site, Facebook. Developed and marketed by Sigma® Life Science, the 'What's Your Favorite Gene?' application is the first and currently only application of its kind available on Facebook, and provides a platform that can enable scientists and researchers to network with each other and facilitate discussion based on their favorite genes, identifiable via gene functionality and biological pathways.
Sanofi and its subsidiary Genzyme announced today positive top-line results from CARE-MS I, the first of two randomized, Phase 3 clinical trials comparing the investigational drug alemtuzumab to the approved multiple sclerosis therapy Rebif in patients with relapsing-remitting multiple sclerosis.
› Verified 4 days ago
Dr. Earle S Linder, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2105 Klockner Rd, Hamilton, NJ 08690 Phone: 609-588-0770 Fax: 609-588-0454 | |
Dr. Phillip S Brackin Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2105 Klockner Rd, Hamilton, NJ 08690 Phone: 609-588-0770 Fax: 609-588-0454 | |
Vitaly Zholudev, M.D Urology Medicare: Accepting Medicare Assignments Practice Location: 2105 Klockner Rd, Hamilton, NJ 08690 Phone: 609-588-0770 Fax: 609-588-0454 | |
Dr. Propa Ghosh, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1374 Whitehorse Hamilton Square Rd Ste 101, Hamilton, NJ 08690 Phone: 609-581-5900 Fax: 609-581-5901 | |
Dr. Mukaram A Gazi, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1374 Whitehorse Hamilton Square Rd, Suite 101, Hamilton, NJ 08690 Phone: 609-581-5900 Fax: 609-581-5901 | |
Samuel A Qassab, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1374 Whitehorse Hamilton Square Rd Ste 101, Hamilton, NJ 08690 Phone: 609-581-5900 |